Results of the multicenter RENEWAL® 3 AVT clinical study of cardiac resynchronization defibrillator therapy in patients with paroxysmal atrial fibrillation

Journal of Cardiovascular Electrophysiology

Volumn 17, Issue 5, 2006, Pages 520-525

  Saxon, Leslie A ^a,g   Greenfield, Ruth Ann ^b   Crandall, Brian G ^c   Nydegger, Charles C ^d   Orlov, Michael ^e   Van Genderen, Rhonda ^f  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^b DUKE UNIVERSITY MEDICAL CENTER   (United States)

^c LDS HOSPITAL   (United States)

^d READING HOSPITAL AND MEDICAL CENTER   (United States)

^e ST ELIZABETH'S MEDICAL CENTER   (United States)

^f BOSTON SCIENTIFIC CORPORATION   (United States)

^g Cardiac Electrophysiology   (United States)

Author keywords

Atrial fibrillation; Biventricular stimulation defibrillation

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; ANTICOAGULANT AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; LOOP DIURETIC AGENT;

ADULT; AGED; ANAMNESIS; ARTICLE; CARDIAC RESYNCHRONIZATION THERAPY; CLINICAL TRIAL; CONVULSIVE THERAPY; DEFIBRILLATOR; DEVICE; DISEASE CLASSIFICATION; DISEASE COURSE; ENERGY; FEMALE; FOLLOW UP; HEART ATRIUM FIBRILLATION; HEART FAILURE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART PROARRHYTHMIA; HEART VENTRICLE ARRHYTHMIA; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PRIMARY PREVENTION; PRIORITY JOURNAL; PROSPECTIVE STUDY; QRS COMPLEX; SINUS RHYTHM; SUDDEN DEATH; SUPRAVENTRICULAR TACHYCARDIA; TREATMENT INDICATION; TREATMENT OUTCOME; ARTIFICIAL HEART PACEMAKER; EQUIPMENT; EQUIPMENT DESIGN; METHODOLOGY; MORTALITY; MULTIMODALITY CANCER THERAPY; PROGNOSIS; RISK ASSESSMENT; RISK FACTOR; STATISTICS; UNITED STATES;

AGED; ATRIAL FIBRILLATION; COMBINED MODALITY THERAPY; DEFIBRILLATORS, IMPLANTABLE; EQUIPMENT DESIGN; EQUIPMENT FAILURE ANALYSIS; FEMALE; HUMANS; MALE; PACEMAKER, ARTIFICIAL; PROGNOSIS; RISK ASSESSMENT; RISK FACTORS; TREATMENT OUTCOME; UNITED STATES;

EID: 33645959229     PISSN: 10453873     EISSN: 15408167     Source Type: Journal    
DOI: 10.1111/j.1540-8167.2006.00440.x     Document Type: Article

References (17)

1. Baily D Lehmann MN Schumacher DN Steinmann RT Meissner MD Hospitalization for arrhythmias in the United States: Importance of atrial fibrillation. Am J Cardiol 1992 19 716 [Abstract].
2. Garg R Packer M Pitt B Yusuf S Heart failure in the 1990s: Evolution of a major public health problem in cardiovascular medicine. J Am Coll Cardiol 1993 22 4 Suppl A 3A 5A.
3. American Heart Association 2002 Heart and Stroke Statistical Update. Dallas American Heart Association 2002.
4. Nohria A Lewis E Stevenson LW Medical management of advanced heart failure. JAMA 2002 287 628 640.
5. Khand A Rankin A Kaye G Cleland J Systematic review of the management of atrial fibrillation in patients with heart failure. Eur Heart J 2000 21 614 632.
6. Agner E Aguinaga L The AF-CHF Trial Investigators Rationale and design of a study assessing treatment of atrial fibrillation in patients with heart failure: The Atrial Fibrillation and Congestive Heart Failure (AF-CHF) trial. Am Heart J 2002 144 597 607.
7. Bristow MR Saxon LA Boehmer J Krueger S Kass DA De Marco T Carson P DiCarlo L DeMets D White BG DeVries DW Feldman AM Comparison of Medical Therapy, Pacing, and Defibrillation in Heart Failure (COMPANION) Investigators. Cardiac-resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure. N Engl J Med 2004 350 2140 2150.
8. Cleland JG Daubert JC Erdmann E Freemantle N Gras D Kappenberger L Tavazzi L Cardiac Resynchronization-Heart Failure (CARE-HF) Study Investigators The effect of cardiac resynchronization on morbidity and mortality in heart failure. N Engl J Med 2005 352 1539 1549.
9. http://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfPMA/pma.cfm. FDA/Center for Devices and Radiological Health searchable website for all CRT & ICD device labels. Accessed June 13, 2005.
10. Ricci R Quesada A Pignalberi C Roda J Disertori M Capucci A Raviele A Santini M Dual defibrillator improves quality of life and decreases hospitalizations in patients with drug refractory atrial fibrillation. J Interv Card Electrophysiol 2004 10 85 92.
11. Savelieva I Camm AJ The results of pacing trials for the prevention and termination of atrial tachyarrhythmias: Is there any evidence of therapeutic breakthrough? J Interv Card Electrophysiol 2003 8 103 115.
12. Ricci R Pignalberi C Santini M Efficacy of atrial antitachycardia functions for treating atrial fibrillation: Observations in patients with a dual-chamber defibrillator. Card Electrophysiol Rev 2003 7 348 351.
13. Bianconi L Castro A Dinelli M Alboni P Pappalardo A Richiardi E Santini M Comparison of intravenously administered dofetilide versus amiodarone in the acute termination of atrial fibrillation and flutter. A multicentre, randomized, double-blind, placebo-controlled study. Eur Heart J 2000 21 1265 1273.
14. Faniel R Schoenfeld P Efficacy of i.v. amiodarone in converting rapid atrial fibrillation and flutter to sinus rhythm in intensive care patients. Eur Heart J 1983 4 180 185.
15. De Marco T Foster E Chatterjee K Dulbecco F Dibs S Saxon LA Cardiac resynchronization therapy: Will ancillary atrial rate support promote greater utilization of ß-blockers in heart failure J Card Fail 2000 40 6 3S.
16. Young JB Abraham WT Smith AL Leon AR Lieberman R Wilkoff B Canby RC Schroeder JS Liem LB Hall S Wheelan K Multicenter InSync ICD Randomized Clinical Evaluation (MIRACLE ICD) Trial Investigators Combined cardiac resynchronization and implantable cardioversion defibrillation in advanced chronic heart failure: The MIRACLE ICD Trial. JAMA 2003 289 2685 2694.
17. Higgins SL Hummel JD Niazi IK Giudici MC Worley SJ Saxon LA Boehmer JP Higginbotham MB De Marco T Foster E Yong PG Cardiac resynchronization therapy for the treatment of heart failure in patients with intraventricular conduction delay and malignant ventricular tachyarrhythmias. J Am Coll Cardiol 2003 42 1454 1459.